Reduced outpatient drug prices
Eligible organizations receive manufacturer pricing established through the federal program.
340B helps eligible safety-net providers purchase outpatient drugs at reduced prices, stretching limited resources to reach more patients and provide more care.
Learn more at HRSAEligible organizations receive manufacturer pricing established through the federal program.
Program value helps providers reach more patients and support essential services.
Missed claims can mean missed savings and less capacity for patient care.
Your existing systems capture what their rules can see. 340BIntel reveals the eligible opportunity they leave behind.
A single retrospective review can surface six figures of recoverable 340B savings that was already yours.
Illustrative example. Actual findings vary by claim volume and program.
Built for hospital compliance teams.
Today, your systems let eligible claims slip away. 340BIntel widens the net to capture the savings you could already be earning.
A narrow field captures some claims while eligible opportunities fall outside the existing rules.
A wider intelligence funnel recaptures missed claims and routes the opportunity back to the hospital.
Six months of claims leave the hospital in one encrypted CSV. Nothing is installed and existing systems stay in place.
The file reaches our team, where it is securely prepared for deeper analysis without disrupting the hospital workflow.
Claims move through the analytical system as rules, relationships, and missed eligibility signals are examined in real time.
Potential savings return to our team for eligibility verification and organization into a clear, defensible audit trail.
A quantified Savings Opportunity Report arrives at the hospital, showing what was missed and the value available to recover.
Scroll to follow the claim
Just data → findings → savings opportunity. Nothing to install, nothing to disrupt.
See the opportunity in your own data before making any financial commitment.
Run a retrospective review without installing or replacing hospital systems.
Use only the access required to verify the claims and savings identified.
Begin with one secure CSV and no upfront implementation expense.
Review quantified findings before making any long-term decision.
Your TPA, pharmacy systems, and staff processes remain in place.
Built for hospital compliance teams from day one.
Built around protected health data from day one.
No on-site access and no additional personnel needed.
Encrypted data exchange — nothing else moves.
Fully traceable EMR and TPA interaction.
Decades of healthcare finance, pharmacy, and compliance experience — focused on finding you more money.
30+ years in finance, healthcare, and high-growth ventures. In 2016, co-founded RLS LLC and led the acquisition of GE Healthcare's U.S. nuclear pharmacy network — sold for $230 million. Has founded multiple companies with successful exits across finance and healthcare sectors.
CFO
CFO and M&A executive with experience across healthcare, energy, mining, and software, including more than $100 million in transactions.
CIO
Technology and operations executive with 29 years of leadership experience in financial services, business operations, and team development.
COODoctor of Pharmacy with hands-on 340B expertise across covered entity and manufacturer-side operations. Certified 340B ACE — the industry's highest operational credential.
CGO20+ years in Fraud, BSA/AML, Corporate Security, and regulatory engagement (BBB, CFPB, state banking). Serves as Chief Growth Officer.
CAO30-year global career across the UK, South Africa, and US. Senior roles at RLS Group in radiopharmaceuticals. Co-founder of Luxuriant & Growth Equity Corp. Deep risk and credit expertise.
Free savings report. No cost. No risk. Real data.
Tell us a little about your program and we'll show you what's being missed. No cost, no risk.